Rekha Jhunjhunwala bought fresh stake in this pharma stock in Q4: Should you buy?
Sun Pharma Advanced Research Company is a mid cap company recorded a market cap of ₹6,305 Cr during Friday closing.
Sun Pharma Advanced Research Company is a mid cap company recorded a market cap of ₹6,305 Cr during Friday's closing. A biopharmaceutical company Sun Pharma Advanced Research Company (SPARC) was established in 2007. It is currently a leader in specialty generics on a worldwide scale. Rekha Jhunjhunwala, the late Rakesh Jhunjhunwala's widowed wife acquired a fresh stake in Sun Pharma Advanced Research during the quarter that ended in March 2023, despite the stock being in the Dalal Street negative zone on a YTD basis.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started